We propose to develop and apply emission tomography (PET) as an analytical biochemical assay technique to study normal human cerebral function and affective disorders. The objectives are: 1.) Chemistry/Biochemistry. Rapid synthetic techniques will be developed and/or improved for preparation of (F-18)-fluoro and (C-11) deoxyglucose for measurement of glucose metabolism, C-11 and N-13 labeled amino acids for measurement of protein synthesis rates and F-18 ligands for receptor assays (principally spiroperidol but also development of high specific activity F-18 labeling techniques to be applied to other ligands). Tissue biochemical assay and autoradiographic studies in rats and monkeys will be used to structure and define kinetic models and select among different tracers for protein synthesis and receptor assay measurements. 2.) Tomography. The NeuroECAT will be upgraded to provide unprecedented level of spatial resolution, image quality and quantification necessary to measure the detailed neuroanatomical components of cerebral function required by this proposal. 3.) Tracer kinetic modeling. Operational equations for measuring cerebral blood flow, protein synthesis, oxygen metabolism and receptor assays will be developed and validated. 4.) Normal Subjects. Studies will be performed to validate methods, and to determine norms and variations in local glucose and oxygen metabolism, blood flow and protein synthesis rates. Studies will be carried out to determine metabolic and blood flow responses to specific sensory stimulations to activate visual, auditory, linguistic and cognitive functions and the use of these stimulation-response tasks as provocative tests for affective disorder patients. 5.) Patients. Local glucose metabolism will be measured in patients with bipolar and unipolar affective disorders to determine if there are measurable local biochemical alterations, to establish the neuroanatomical distribution and magnitude of the functional changes and to objectively evaluate the metabolic consequences of drugs administered diagnostically (Ritalin - unipolar, depressed and also normal volunteers as controls) and therapeutically (Lithium - bipolar). Success in basic studies of F-18 spiroperidol will allow studies in these patients to examine the dopamine hypothesis of manic/depressive disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH037916-04
Application #
3376404
Study Section
(SRC)
Project Start
1983-06-01
Project End
1988-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Organized Research Units
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hovda, David A; Villablanca, Jaime R; Chugani, Harry T et al. (2006) Metabolic maturation of the brain: a study of local cerebral protein synthesis in the developing cat. Brain Res 1113:54-63
Martinez, Z A; Colgan, M; Baxter Jr, L R et al. (1997) Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. Am J Primatol 42:215-24
Schwartz, J M; Stoessel, P W; Baxter Jr, L R et al. (1996) Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 53:109-13
Melega, W P; Quintana, J; Raleigh, M J et al. (1996) 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 22:63-9
Cherry, S R; Woods, R P; Doshi, N K et al. (1995) Improved signal-to-noise in PET activation studies using switched paradigms. J Nucl Med 36:307-14
Melega, W P; Williams, A E; Schmitz, D A et al. (1995) Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274:90-6
Grafton, S T; Martin, N A; Mazziotta, J C et al. (1994) Localization of motor areas adjacent to arteriovenous malformations. A positron emission tomographic study. J Neuroimaging 4:97-103
Baxter Jr, L R (1994) Positron emission tomography studies of cerebral glucose metabolism in obsessive compulsive disorder. J Clin Psychiatry 55 Suppl:54-9
Yu, D C; Huang, S C; Grafton, S T et al. (1993) Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies. J Nucl Med 34:679-88
Woods, R P; Mazziotta, J C; Cherry, S R (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17:536-46

Showing the most recent 10 out of 99 publications